JP2016516774A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016516774A5 JP2016516774A5 JP2016507609A JP2016507609A JP2016516774A5 JP 2016516774 A5 JP2016516774 A5 JP 2016516774A5 JP 2016507609 A JP2016507609 A JP 2016507609A JP 2016507609 A JP2016507609 A JP 2016507609A JP 2016516774 A5 JP2016516774 A5 JP 2016516774A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- composition
- light
- bioactive agent
- wavelength
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361809695P | 2013-04-08 | 2013-04-08 | |
| US61/809,695 | 2013-04-08 | ||
| PCT/US2014/033337 WO2014168950A1 (en) | 2013-04-08 | 2014-04-08 | Photo-responsive compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016516774A JP2016516774A (ja) | 2016-06-09 |
| JP2016516774A5 true JP2016516774A5 (https=) | 2017-06-01 |
Family
ID=51689955
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016507609A Withdrawn JP2016516774A (ja) | 2013-04-08 | 2014-04-08 | 光応答性化合物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20160144031A1 (https=) |
| EP (1) | EP2983677A4 (https=) |
| JP (1) | JP2016516774A (https=) |
| CN (1) | CN105307663A (https=) |
| WO (1) | WO2014168950A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8524239B2 (en) | 2010-07-09 | 2013-09-03 | The United States of America as represented by the Secrectary, Department of Health and Human Services | Photosensitizing antibody-fluorophore conjugates |
| SG11201610052TA (en) | 2014-08-08 | 2017-02-27 | Us Health | Photo-controlled removal of targets in vitro and in vivo |
| CN108137701A (zh) | 2015-08-07 | 2018-06-08 | 美国政府(由卫生和人类服务部的部长所代表) | 用于治疗癌症的针对抑制细胞的近红外光免疫疗法(nir-pit) |
| CN119564879A (zh) | 2015-08-18 | 2025-03-07 | 乐天医药生技股份有限公司 | 用于光免疫疗法的组合物、联用及相关方法 |
| AU2016308286B2 (en) | 2015-08-18 | 2022-04-07 | Rakuten Medical, Inc. | Phthalocyanine dye conjugates and their storage |
| WO2020113130A1 (en) * | 2018-11-29 | 2020-06-04 | The Trustees Of Dartmouth College | Tumor targeting vitamin b12 derivatives for x-ray activated chemotherapy |
| US20220259272A1 (en) * | 2019-06-14 | 2022-08-18 | The University Of North Carolina At Chapel Hill | Photoactive compositions for therapuetic agent delivery |
| CN110215179B (zh) * | 2019-06-20 | 2022-02-25 | 京东方科技集团股份有限公司 | 胶囊内窥镜的释药装置及胶囊内窥镜 |
| CN112168977A (zh) * | 2020-10-27 | 2021-01-05 | 西南大学 | 转铁蛋白修饰的二氧化硅荷载白藜芦醇及制备方法和应用 |
| CN114216982B (zh) * | 2021-12-14 | 2024-08-09 | 黑龙江飞鹤乳业有限公司 | 维生素b12的检测方法 |
| WO2026030557A1 (en) * | 2024-07-31 | 2026-02-05 | The University Of North Carolina At Chapel Hill | Compositions and methods for tissue protection and therapuetic agent delivery |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE298344T1 (de) * | 1996-08-27 | 2005-07-15 | Univ Utah Res Found | Biokonjugate und verabreichung von bioaktiven substanzen |
| US8076318B2 (en) * | 2002-10-24 | 2011-12-13 | Albert Einstein College Of Medicine Of Yeshiva University | Caged ligands and uses thereof |
| US7271886B2 (en) * | 2002-11-18 | 2007-09-18 | Panomics, Inc. | Uncaging device |
| CA2505603A1 (en) * | 2002-11-18 | 2004-06-03 | Genospectra, Inc. | Caged sensors, regulators and compounds and uses thereof |
| US7759459B2 (en) * | 2003-01-10 | 2010-07-20 | Albert Einstein College Of Medicine Of Yeshiva University | Fluorescent assays for protein kinases |
| US9744236B2 (en) * | 2009-06-26 | 2017-08-29 | The Trustees Of Columbia University In The City Of New York | Photolabile compounds |
-
2014
- 2014-04-08 CN CN201480020282.XA patent/CN105307663A/zh active Pending
- 2014-04-08 JP JP2016507609A patent/JP2016516774A/ja not_active Withdrawn
- 2014-04-08 EP EP14782268.8A patent/EP2983677A4/en not_active Withdrawn
- 2014-04-08 US US14/779,387 patent/US20160144031A1/en not_active Abandoned
- 2014-04-08 WO PCT/US2014/033337 patent/WO2014168950A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016516774A5 (https=) | ||
| ES2409069B2 (es) | Uso de aglutinantes para fabricar formulaciones estables al almacenamiento | |
| CL2008000180A1 (es) | Sal tosilato de trans-n-etil-3-fluoro-3-[3-fluoro-4-(pirrolidin-1-ilmetil)fenil]ciclobutanocarboxamida; composicion farmaceutica; y uso para el tratamiento de enfermedades tales como depresion, trastornos del sueno, ansiedad y enfermedades del tracto | |
| CY2017013I1 (el) | ΑΝΤΙΣΩΜΑ ΕΝΑΝΤΙΟΝ PDGFR-α ΓΙΑ ΧΡΗΣΗ ΣΤΗΝ ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ ΟΓΚΩΝ | |
| CY1119960T1 (el) | Μεθοδοι για την αυξηση της αποτελεσματικοτητας της folr1 θεραπειας του καρκινου | |
| BR112015023333A8 (pt) | pirrolbenzodiazepinas e conjugados dos mesmos | |
| CL2007003635A1 (es) | Compuestos derivados de 6-amino-purin-8-ona; proceso de preparacion; composicion farmaceutica; proceso para preparar la composicion farmaceutica; y uso en el tratamiento de enfermedades alergicas, virales o cancer. | |
| JP2015525757A5 (https=) | ||
| CL2007001131A1 (es) | Compuestos derivados de purina sustituida; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de una enfermedad inflamatoria u obstructiva de las vias respiratorias. | |
| BR112012026213A8 (pt) | Compostos de pirrolobenzodiazepinas, conjugado das mesmas, composição farmacêutica compreendendo o conjugado e uso do mesmo para o tratamento de uma doença proliferativa | |
| UY33029A (es) | Antagonistas de espiro-oxindol de mdm2 | |
| BRPI0922771A2 (pt) | agentes indutores de apoptose seletivos para bcl-2 para o tratamento de câncer e doenças imunes | |
| GT201400069A (es) | Composiciones farmaceuticas | |
| CL2012001836A1 (es) | Compuestos de pirazol, antagonista de crth2; composicion farmacéutica; uso en el tratamiento de trastornos inflamatorios, infecciosos, inmunoreguladores, enfermedades respiratorias, gastrointestinales o dolencias, entre otros. | |
| JP2015532296A5 (https=) | ||
| MX361778B (es) | Composiciones farmaceuticas y metodos de tratamiento. | |
| IL200044A (en) | Tricyclic compounds as modulators of a glucocorticoid receptor and their use in the preparation of drugs for the treatment of diseases | |
| SI1940409T1 (sl) | Nove zdravilske kombinacije za zdravljenje bolezni dihalnih poti | |
| ES2550461T3 (es) | Uso de S-adenosilmetionina (SAM) y superóxido dismutasa (SOD) para la preparación de medicamentos para el tratamiento de la enfermedad de Alzheimer | |
| CL2008003232A1 (es) | Compuestos derivados de bencensulfonanilida; composición farmacéutica que los comprende; y uso en el tratamiento de enfermedades del sistema nervioso central, disfunciones cognitivas, esquizofrenia, enfermedades adictivas, enfermedad de alzheimer u obesidad. | |
| CL2008000804A1 (es) | Uso de una sal de cobre enmascarada o recubierta en una composicion farmaceutica para el tratamiento de una enfermedad tratable a traves de una sal de cobre como degeneracion macular; material de capsula digerible. | |
| JP2018508589A5 (https=) | ||
| CL2012001182A1 (es) | Compuestos derivados de 4h-cromen-4-ona, moduladores de quinasa pi3k; composición farmacéutica que los comprende, y su uso en el tratamiento de cáncer, enfermedades hepáticas, renales, inmunitarias, entre otras. | |
| Moshkelani | Investigation of multi-functional theranostic liposomes and bimodal combination therapy of cancer | |
| Fišerová et al. | Comprehensive interrogation of the cellular response to fluorescent, detonation and functionalized nanodiamonds Nanodiamonds are versatile, carbon nanoparticles that have been gaining popularity in applications ranging from solar cells to drug delivery. Dr. Dean Ho’s research team is currently developing |